Outcomes on the use of hemospray in upper gastrointestinal bleeds secondary to tumours: Outcomes from the multicentre international hemospray registry

(1) University College London Hospital,London,United Kingdom

(2) Washington University School Of Medicine, St Louis, Mo,Washington,United States

(3) Nottingham University Hospital,Nottingham,United Kingdom

(4) Guys and St Thomas Hospitals,London,United Kingdom

(5) Horst Schmidt Kliniken,Wiesbaden,Germany

(6) Kings College Hospital,London,United Kingdom

(7) Bradford Hospitals Foundation Trust,Bradford,United Kingdom

(8) Gloucestershire Hospitals NHS Foundation Trust,Gloucestershire,United Kingdom

(9) University of Nantes,Nantes,France

(10) University Hospital Southampton,Southampton,United Kingdom

(11) Belfast City Hospital,Belfast,United Kingdom

(12) Royal Free Hospital,London,United Kingdom

(13) Universitätsklinikum Tübingen,Tübingen,Germany

(14) Portsmouth University Hospital,Portsmouth,United Kingdom

(15) University College London,London,United Kingdom

This item was part of the Trends in treatment and detection of upper GI bleeding (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019